Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Avatrombopag
100%
Inpatient Medicine
100%
Severe Thrombocytopenia
100%
Lactic Acidosis
100%
Clinical Impact
100%
Sputum Specimens
100%
Multiplex
100%
Intensive Care Unit Patients
100%
Lower Respiratory Tract Infection
100%
Non-intensive Care Unit
100%
Biofire Pneumonia Panel
100%
Bacteria Detection
100%
Standard of Care
72%
Fluconazole
28%
Ciprofloxacin
28%
Thrombopoietin Receptor Agonist (TPO-RA)
28%
Antibiotics
18%
Antibiotic Appropriateness
18%
Antibiotic Regimen
18%
Eltrombopag
14%
Immune Thrombocytopenia
14%
Rechallenge
14%
Sepsis
14%
Drug Discontinuation
14%
Anion Gap Metabolic Acidosis
14%
Diabetic Ketoacidosis
14%
Lactate Level
14%
Ischemia
14%
Neutropenia
14%
Hypovolemia
14%
Thrombocytopenia
14%
Elevated Lactate
14%
Metabolism
14%
Increasing Dose
14%
Isolated Thrombocytopenia
14%
Dose-dependent
14%
Retrospective Cohort Study
9%
Gram-negative
9%
Academic Medical Centers
9%
Oncology
9%
Healthcare Culture
9%
Tertiary Referral
9%
Non-neutropenic Patients
9%
Neutropenic Patients
9%
Gram-positive
9%
Therapeutic Change
9%
Medicine and Dentistry
Bacterium
100%
Pathogen
100%
Intensive Care Unit
100%
Pneumonia
100%
Sputum
100%
Lower Respiratory Tract Infection
100%
Antimicrobial Agent
36%
Oncology
9%
Patient Referral
9%
Retrospective Cohort Study
9%
Pharmacology, Toxicology and Pharmaceutical Science
Avatrombopag
100%
Lactic Acidosis
100%
Thrombocytopenia
100%
Fluconazole
28%
Ciprofloxacin
28%
Eltrombopag
14%
Refractory Thrombocytopenia
14%
Receptor Agonist
14%
Ischemia
14%
Idiopathic Thrombocytopenic Purpura
14%
Diabetic Ketoacidosis
14%
Metabolic Acidosis
14%
Neutropenia
14%
Lactic Acid
14%
Hypovolemia
14%
Sepsis
14%
Thrombopoietin Receptor
14%